As capital rotation intensifies across micro- and small-cap equities in 2026, a new wave of sub-$10 stocks is gaining traction among investors seeking exposure to high-growth themes including immunotherapy breakthroughs,…
Shares of 1606 Corp. (OTC: CBDW) are gaining increased investor attention after the company announced a pair of strategic developments tied to its expanding AI data center and energy infrastructure…
Four companies—Health In Tech (NASDAQ: HIT), Synergy CHC Corp (NASDAQ: SNYR), SurgePays (NASDAQ: SURG), and Kartoon Studios (NYSE American: TOON)—are emerging in a “March Madness Undervalued Watch” theme, gaining investor…
Full Alliance Group (OTCQB: FAGI) continues executing its multi-vertical growth strategy as its subsidiary Aquaox Pure Solutions, LLC reports accelerating marketplace traction for JusSpray™, the company’s flagship hypochlorous acid (HOCl)…
While investors chase the obvious opportunity in the emerging MASH drug market, another potentially powerful theme is developing just beneath the surface. Diagnostics. If metabolic dysfunction–associated steatohepatitis becomes a widely…
Virtuix Holdings, Inc. (NASDAQ: VTIX) CEO Jan Goetgeluk recently joined “The Street Reports Podcast” to discuss the company’s evolution from a crowdfunding-backed startup to a publicly traded Nasdaq company, while…
Antimony is rapidly emerging as one of the most strategically important critical minerals in the global resource race, particularly as defense technology, aerospace systems, and advanced electronics continue to expand.…
The U.S. blank apparel and textile manufacturing industry continues to expand as demand for customizable clothing, uniforms, and branded merchandise accelerates across corporate, promotional, and retail markets. One of the…
Investors searching for stocks under $1 with emerging catalysts are increasingly turning their attention to a mix of media, artificial intelligence, healthcare technology, and energy companies that are generating fresh…
The global absorbable hydrogel tissue spacer market, used primarily in prostate cancer radiation therapy, is gaining momentum as healthcare providers increasingly adopt technologies designed to reduce treatment side effects while…
